ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Bush Proposes $2.8 Billion Increase For NIH In FY2002, Vows $4.1B Next Year.

March 2, 2001

HHS Forms Office for Recovery Act

March 13, 2009

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010

Ford Named Acting CORB Chief; Hunter CCOP Coordinator

July 10, 1987

House Passes Cancer Bill With Mandates for NCI

September 28, 2012

NCI Unconventional Innovations Program releases Broad Agency Announcement.

October 24, 2003